A randomised controlled trial of intramuscular vs. intravenous antivenom for latrodectism - The RAVE study

QJM: An International Journal of Medicine

Volumn 101, Issue 7, 2008, Pages 557-565

  Isbister, Geoffrey K ^a,b,c   Brown, S G A ^d,e   Miller, M ^f   Tankel, A ^g   Macdonald, E ^d,e   Stokes, B ^c   Ellis, R ^d,e   Nagree, Y ^d,e   Wilkes, G J ^e,h   James, R ^b   Short, A ⁱ   Holdgate, A ⁱ  

^a CHARLES DARWIN UNIVERSITY   (Australia)

^b CALVARY MATER NEWCASTLE HOSPITAL   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

^d FREMANTLE HOSPITAL   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f JOHN HUNTER HOSPITAL   (Australia)

^g 30 Park Avenue   (Australia)

^h UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

ⁱ LIVERPOOL HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE; PLACEBO; VENOM ANTISERUM;

ADULT; ARTICLE; BAYES THEOREM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; ENVENOMATION; FEMALE; HUMAN; LATRODECTISM; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PAIN ASSESSMENT; POISONOUS SPIDER; PRIORITY JOURNAL; PROBABILITY; RANDOMIZED CONTROLLED TRIAL; SERUM SICKNESS; SLEEP DISORDER; SPIDER BITE;

EID: 46249120194     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcn048     Document Type: Article

References (25)

1. Clark RF, Wethern-Kestner S, Vance MV, Gerkin R. Clinical presentation and treatment of black widow spider envenomation: A review of 163 cases. Ann Emerg Med 1992; 21:782-87.
2. Muller GJ. Black and brown widow spider bites in South Africa. A series of 45 cases. S Afr Med J 1993; 83:399-405.
3. de Haro L, David JM, Jouglard J. Latrodectism in southern France. A series of cases from the poisoning center of Marseille. Presse Med 1994; 23:1121-3.
4. Artaza O, Fuentes J, Schindler R. Latrodectism: Clinicotherapeutical evaluation of 89 cases. Rev Med Chil 1982; 110:1101-5.
5. Sutherland SK, Trinca JC. Survey of 2144 cases of red-back spider bites: Australia and New Zealand, 1963-1976. Med J Aust 1978; 2 620-3.
6. Isbister GK, White J. Clinical consequences of spider bites: Recent advances in our understanding. Toxicon 2004; 43:477-92.
7. Isbister GK, Graudins A, White J, Warrell D. Antivenom treatment in arachnidism. J Toxicol. Clin Toxicol 2003; 41:291-300.
8. Wiener S. Redback spider bite in Australia: An analysis of 167 cases. Med J Aust 1961; 11:44-9.
9. Wiener S. Latrodectism: A prospective cohort study of bites by formally identified redback spiders. Med J Aust 2003; 179:455-6.
10. Sutherland SK. Acute untoward reactions to antivenoms. Med J Aust 1977; 2:841-2.
11. Isbister GK. Failure of intramuscular antivenom in redback spider envenomation. Emerg Med 2002; 14:436-39.
12. Krifi MN, Savin S, Debray M, Bon C, El Ayeb M, Choumet V. Pharmacokinetic studies of scorpion venom-before and after antivenom immunotherapy. Toxicon 2005; 45:187-98.
13. Krifi MN, Amri F, Kharrat H, El Ayeb M. Evaluation of antivenom therapy in children severely envenomed by Androctonus australis garzonii (Aag) and Buthus occifanus tunetanus (Bot) scorpions. Toxicon 1999; 37:1627-34.
14. Riviere G, Choumet V, Audebert F, et al. Effect of antivenom on venom pharmacokinetics in experimentally envenomed rabbits: Toward an optimization of antivenom therapy. J Pharmacol Exp Ther 1997; 281:1-8.
15. Isbister GK. Data collection in clinical toxinology: Debunking myths and developing diagnostic algorithms. J Toxicol Clin Toxicol 2002; 40:231-7.
16. Isbister GK, Gray MR. Latrodectism: A prospective cohort study of bites by formally identified redback spiders. Med J Aust 2003; 179 88-91.
17. Ellis RM, Sprivulis PC, Jelinek GA, et al. A double-blind, randomized trial of intravenous versus intramuscular antivenom for Red-back spider envenoming. Emerg Med Australas 2005; 17 152-6.
18. Isbister GK, O'Leary MA, Miller M, Brown SGA, Ramasamy S, James R, Schneider JJ. A comparison of serum antivenom concentrations after intravenous and intramuscular administration of redback (widow) spider antivenom. Br J Clin Pharmacol 2008; 65:139-43.
19. Brown SG. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol 2004; 114:371-6.
20. Bird SB, Dickson EW. Clinically significant changes in pain along the visual analog scale. Ann Emerg Med 2001; 38:639-43.
21. Loten C, Stokes B, Worsely D, Seymour JE, Jiang S, Isbister GK. A randomized controlled trial of hot water (45°C) immersion versus ice packs for pain relief in Physalia stings. Med J Aust 2006; 184:329-33.
22. Parmar MK, Griffiths GO, Spiegelhalter DJ, Souhami RL, Altman DG, van der SE. Monitoring of large randomised clinical trials: A new approach with Bayesian methods. Lancet 2001; 358:375-81.
23. Brown SG, Isbister GK, Stokes B. Route of administration of redback spider bite antivenom: Determining clinician beliefs to facilitate Bayesian analysis of a clinical trial. Emerg Med Australas 2007; 19:458-63.
24. Berry DA. A case for Bayesianism in clinical trials. Stat Med 1993; 12:1377-93.
25. Lau J, Schmid CH, Chalmers TC. Cumulative meta-analysis of clinical trials builds evidence for exemplary medical care. J Clin Epidemiol 1995; 48:45-57.